Use of single-point mutated HMGB1 box a variants as therapeutic agents in HMGB1 and rage related pathologies

被引：0
|
作者：
Lorenzetto, Chiara
Fumero, Silvano
Barone, Domenico
Traversa, Silvio
Guyon, Thierry
Borrelly, Gilles
机构：
来源：
INFLAMMATION RESEARCH | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：S190 / S190
页数：1
相关论文
共 50 条
  • [1] Design of a selected single-point mutated HMGB1 box a variant as therapeutic agent in HMGB1 and RAGE related pathologies
    Lorenzetto, C.
    Barone, D.
    Borrelly, G.
    Drittanti, L.
    Guyon, T.
    Morena, S.
    Oderda, C.
    Odrzywol, K.
    Traversa, S.
    Fumero, S.
    PROCEEDINGS OF THE 7TH WORLD CONGRESS ON TRAUMA, SHOCK, INFLAMMATION AND SEPSIS, 2007, : 87 - +
  • [2] An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
    Musumeci, Domenica
    Roviello, Giovanni N.
    Montesarchio, Daniela
    PHARMACOLOGY & THERAPEUTICS, 2014, 141 (03) : 347 - 357
  • [3] HMGB1 and RAGE in Inflammation and Cancer
    Sims, Gary P.
    Rowe, Daniel C.
    Rietdijk, Svend T.
    Herbst, Ronald
    Coyle, Anthony J.
    ANNUAL REVIEW OF IMMUNOLOGY, VOL 28, 2010, 28 : 367 - 388
  • [4] Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
    Yang, Huan
    Liu, Hui
    Zeng, Qiong
    Imperato, Gavin H.
    Addorisio, Meghan E.
    Li, Jianhua
    He, Mingzhu
    Cheng, Kai Fan
    Al-Abed, Yousef
    Harris, Helena E.
    Chavan, Sangeeta S.
    Andersson, Ulf
    Tracey, Kevin J.
    MOLECULAR MEDICINE, 2019, 25 (1)
  • [5] Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
    Huan Yang
    Hui Liu
    Qiong Zeng
    Gavin H. Imperato
    Meghan E. Addorisio
    Jianhua Li
    Mingzhu He
    Kai Fan Cheng
    Yousef Al-Abed
    Helena E. Harris
    Sangeeta S. Chavan
    Ulf Andersson
    Kevin J. Tracey
    Molecular Medicine, 2019, 25
  • [6] Establishment of in vitro binding assay of high mobility group box-1 to RAGE and the Examination into effect of HMGB1 domain peptides on the binding of HMGB1 to RAGE
    Okamura, Mai
    Wake, Hidenori
    Liu, Rue
    Liu, Keyue
    Izushi, Yasuhisa
    Takahasi, Hideo
    Nishibori, Masahiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 165P - 165P
  • [7] The Role of HMGB1/RAGE in Inflammatory Cardiomyopathy
    Volz, Hans C.
    Kaya, Ziya
    Katus, Hugo A.
    Andrassy, Martin
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2010, 36 (02): : 185 - 194
  • [8] HMGB1/RAGE in the regulation of cell motility
    Rauvala, Heikki
    JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 84 (02) : A7 - A7
  • [9] Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases
    Singh, Harbinder
    Agrawal, Devendra K.
    MOLECULES, 2022, 27 (21):
  • [10] HMGB1 as a therapeutic target in disease
    Xue, Jiaming
    Suarez, Joelle S.
    Minaai, Michael
    Li, Shuangjing
    Gaudino, Giovanni
    Pass, Harvey I.
    Carbone, Michele
    Yang, Haining
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (05) : 3406 - 3419
12345